Non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Voluntarily participate in the study, fully understand and know about the study and sign the informed consent; Patients with primary non-small cell lung cancer with clear histological and pathological evidence; Aged 18-80 years old (inclusive); ECOG score is less than 2 points; Patients with non-small cell lung cancer who have progressed after prior systemic chemotherapy; may have CT or MRI evaluate the lesion and have at least one evaluation result; During the study, patients were advised to stop smoking and drinking, and avoid spicy and irritating food.
Exclusion criteria
Exclusion criteria: Exclude patients with autoimmune diseases and digestive diseases; Patients with secondary primary malignancy were excluded; Antibiotics, laxative drugs, immunosuppressants, microecological preparations and other treatments within 1 month are excluded of patients; Patients with infectious diseases such as viral hepatitis, HIV and syphilis are excluded; High-dose hormonal treatment is required in the near term, active brain metastases require treatment, meninges metastases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Disease control rate;Duration of remission;Time to progression;Overall survival; | — |
Countries
China
Contacts
The Second Hospital of Dalian Medical University